Disclaimer: This content is for informational and educational purposes only and should not be construed as financial or investment advice. Always do your own research and consult a licensed financial advisor before making investment decisions.

Free Tier

Next Arc Research Company Analysis
125 of 125
Total Stocks
Month
Update Cadence
Risk Level (select to filter)
Opportunity Level (select to filter)
Segments (select to filter)
Risk-Weighted Opportunity Quartiles (select to filter)
Showing 0 of 0 stocks
Color by Risk-Weighted Opportunity: Q1 (Low) Q2 Q3 Q4 (High)
# Symbol Segments Name Multiple Alignment Thesis
1 NNOX ai hardware healthcare medical devices software Nano-X Imaging Ltd. 19.2x 0.40 Nanox is a financing-gated option on turning low-cost imaging placements into recurring scan, report, AI, and health-IT revenue; if it proves live-site utilization and shifts value capture from one-time hardware to contracted workflow services, the equity can rerate materially by 2031 despite a still-imperfect margin profile.
2 RR ai automation hardware robotics software Richtech Robotics Inc. 5.9x 0.42 Richtech is a cash-rich microcap physical-AI option: if it converts real deployments, Alphamax operating sites, and teleoperation data into repeatable multi-site recurring contracts, the operating business can re-rate sharply from a tiny base; if not, it remains a support-heavy niche robot vendor with a trust discount.
3 AISP ai cybersecurity defense enterprise software Airship AI Holdings, Inc. 5.3x 0.50 Airship can create several-fold equity value if it converts permissioned security demand into repeatable awards, then captures more of each deployment through software, maintenance, and trust-oriented workflow layers on top of installed camera and sensor estates.
4 HURA biotech healthcare TuHURA Biosciences, Inc. 4.7x 0.30 If IFx-2.0 reaches market in Merkel cell carcinoma and management monetizes ex-U.S. rights before over-diluting the cap table, HURA can move from a pre-revenue science option into a small orphan-oncology franchise by 2031; the upside comes from low starting value and milestone-driven rerating, not from a blockbuster market.
5 NTLA biotech healthcare Intellia Therapeutics, Inc. 4.7x 0.40 The non-linear case is that lonvo-z turns Intellia from a collaboration-funded CRISPR story into a real rare-disease franchise, while nex-z recovery and selective licensing let it monetize hard-to-copy editing know-how more than once. If the first commercial in vivo KLKB1 edit builds trusted reimbursement and follow-up rails, 2031 value can rise much faster than current revenue suggests.
6 SERV ai automation healthcare robotics transportation Serve Robotics Inc. 4.6x 0.56 Serve can still turn a tiny revenue base into a meaningful multi-vertical robot network if it replaces Uber-led demand with broader partner flow, deepens hospital workflows, and captures more value through workflow, trust, and financing layers rather than charging mainly for robot activity.
7 PDYN ai automation defense robotics software Palladyne AI Corp. 4.2x 0.60 Palladyne AI can plausibly grow from a proving-stage micro-cap into a meaningful defense-autonomy supplier if SwarmOS, BRAIN X2, and IAI-linked HARPY/HAROP programs convert exercises and backlog into repeat awards, then attach assurance, sustainment, and retrofit economics before dilution eats the upside.
8 KDK ai automation defense software transportation Kodiak AI, Inc. 4.2x 0.64 Kodiak is a real physical-AI commercialization option: if it converts Atlas proof, a year-end long-haul launch, and workflow integration into a repeatable customer-owned fleet model, revenue can scale non-linearly from a tiny base; the main leak is dilution and delayed permissioning before that flywheel matures.
9 PRME biotech healthcare Prime Medicine, Inc. 4.1x 0.40 PRME is a leveraged platform option: if PM359 reaches a real filing and the 2027 liver readouts validate PM577a and PM647 before capital pressure forces weak financing, a sub-scale collaboration-revenue biotech can rerate into a reusable rare-disease editing franchise with product, licensing, and data-rights upside.
10 RXRX ai automation biotech healthcare Recursion Pharmaceuticals, Inc. 4.1x 0.60 Recursion can rerate from an AI-biotech narrative into an early medicine engine if REC-4881 gets an approval-oriented path, one additional internal program shows credible human proof, and the company monetizes its data-and-lab loop through a better mix of product, milestone, royalty, and standardized external discovery revenue.
11 DNA ai automation biotech healthcare robotics Ginkgo Bioworks Holdings, Inc. 4.1x 0.45 DNA is a proof-driven infrastructure rerating: if Ginkgo turns its Boston autonomous lab from lumpy project capacity into a repeatable execution rail for AI-enabled biology, modest share gains in a much larger automated R&D market can more than double equity value by 2031 despite financing friction.
12 AI ai automation cloud enterprise software C3.ai, Inc. 3.8x 0.32 C3 AI has a real enterprise AI stack and enough liquidity to attempt a serious reset; if it converts IPDs into repeatable production deployments and shifts value capture toward governed execution, regulated trust, and partner-embedded vertical solutions, revenue can compound much faster than the Street expects, though software commoditization likely caps upside in the 2-5x zone rather than a 10x outcome.
13 BEAM biotech healthcare Beam Therapeutics Inc. 3.7x 0.40 Beam can compound by converting from a cash-backed editing platform into a multi-franchise rare-disease company: risto-cel can establish the first commercial beachhead, BEAM-302 can validate a reusable in vivo liver-editing engine, and follow-on liver programs can add non-linear value if regulatory and CMC execution hold.
14 ACHR aerospace ai defense evtol transportation Archer Aviation Inc. 3.7x 0.60 Archer has a realistic path to become more than an eVTOL prototype story: if Midnight reaches initial service, the Boeing asset deal closes, and recurring mission-support revenue attaches to fleets, the company can compound from tiny revenue into a broader regulated aviation platform by 2031.
15 MSTR ai crypto enterprise finance software Strategy Inc 3.4x 0.40 Strategy can still compound at a venture-like rate if it preserves the listed bitcoin funding flywheel, keeps reserve coverage credible through the 2027 liability gates, and turns treasury credibility into higher-margin trust, workflow, and liquidity fees; the upside does not require a software miracle, but it does require the common and preferred stack to stay financeable.
16 POET ai communications hardware networking semiconductors POET Technologies Inc. 3.4x 0.62 POET is a cash-funded option on a real AI bandwidth bottleneck: if 2026-2027 qualification and Malaysia ramp convert partner activity and the Lumilens framework into repeat 800G, 1.6T and light-source shipments, revenue can jump from micro-scale to a meaningful niche optics franchise; if not, it stays an expensive promise.
17 RCAT aerospace automation defense hardware robotics Red Cat Holdings, Inc. 3.2x 0.55 Red Cat can still create a solid 2x-3x equity outcome by 2031 if it converts current U.S. and allied validation into repeat production, broadens beyond one major customer, and attaches more recurring readiness and verification revenue to a trusted-source drone fleet.
18 FLNC automation energy enterprise software Fluence Energy, Inc. 3.1x 0.60 If Fluence fixes its manufacturing ramp and funds the working-capital hump, AI load growth and grid-flexibility demand can turn it from a low-margin storage integrator into a larger, more trusted storage-and-controls platform; the 5-year upside is driven by backlog conversion and a modest rerating, not a software fantasy.
19 INOD ai cybersecurity enterprise software Innodata Inc. 3.1x 0.58 Innodata can grow well beyond a classic IT-services outcome if it converts frontier-lab know-how into reusable datasets, evaluation controls, and trusted AI operations while reducing customer concentration; that creates a credible path to much higher revenue quality, though not a pure-software end state.
20 APLD ai cloud crypto energy hardware Applied Digital Corporation 3.0x 0.76 Applied Digital can grow into a much larger AI-infrastructure owner if it keeps turning scarce powered sites and signed leases into live campuses on schedule; the nonlinear upside comes from classification change from speculative builder to scarce capacity landlord, but common-equity capture still depends on financing discipline.
21 IREN ai cloud crypto energy hardware IREN Limited 3.0x 0.74 IREN is a leveraged bet on AI compute scarcity: if it keeps turning scarce grid-connected power, financed GPUs and signed demand into customer-accepted capacity faster than peers, revenue can scale into a meaningful AI infrastructure platform by 2031, though returns will still be capped by capital intensity and periodic pricing resets.
22 OKLO defense energy healthcare nuclear Oklo Inc. 3.0x 0.72 Oklo is a scarce AI-era power option: if it turns Groves learning, Aurora-INL startup, Ohio campus execution, and fuel access into a repeatable contracted-capacity model, it can re-rate from pre-revenue developer to early clean-baseload platform by 2031.
23 QUBT ai defense hardware quantum semiconductors Quantum Computing Inc. 3.0x 0.48 QCi can create nonlinear value over five years if it converts its unusually large liquidity base and newly assembled U.S. photonics stack into repeatable foundry, packaging, secure-communications, and edge-AI system revenue; the upside comes from becoming a scarce industrial supplier, not from winning general-purpose quantum computing.
24 AMPX aerospace defense energy hardware transportation Amprius Technologies, Inc. 2.9x 0.62 If Amprius can turn its chemistry edge into reliable partner-made SiCore volume, it can become a premium tollbooth on endurance-critical drones, defense systems, and lightweight mobility as AI and autonomy expand the need for better onboard energy.
25 MBLY ai automation automotive semiconductors software Mobileye Global Inc. 2.9x 0.60 Mobileye can compound at roughly bull-consensus rates if late-2026 and 2027 launches convert its large installed base into richer per-vehicle autonomy content, while road data, safety validation, and selective recurring software economics keep it from being valued like a plain auto chip supplier.
26 SDGR ai biotech enterprise healthcare software Schrödinger, Inc. 2.9x 0.58 The five-year upside is a business-model upgrade: if hosted delivery, LiveDesign embedding, and Bunsen shift Schrödinger from tool vendor to program-level workflow owner, rising discovery throughput can convert into cleaner recurring software revenue plus selective milestone upside, driving a credible 2x+ equity outcome without needing a single binary drug win.
27 AUR ai automation robotics software transportation Aurora Innovation, Inc. 2.8x 0.65 Aurora is past pure concept risk; if its 2026-2027 fleet, safety, and OEM milestones convert a few working driverless lanes into repeatable deployment, it can grow from a tiny revenue base into a real autonomous freight network, but the likely equity outcome is a strong 2-5x rather than a venture-style 10x because financing, regulation, and partner bargaining will absorb part of the value.
28 NBIS ai automation cloud enterprise software Nebius Group N.V. 2.8x 0.76 Nebius can turn scarce power, GPUs, and signed AI demand into a much larger AI-utility revenue base; if partner capacity and trust software scale before scarcity rents fade, revenue can compound fast enough to outrun dilution and roughly triple equity value by 2031.
29 SPIR aerospace communications defense software space Spire Global, Inc. 2.8x 0.60 Spire can grow from a subscale satellite-data vendor into a trusted orbital intelligence utility if recent weather and government wins become repeatable operating programs, raising revenue density on its satellite-and-ground stack faster than financing pressure returns.
30 WULF ai cloud crypto energy TeraWulf Inc. 2.8x 0.72 TeraWulf is shifting from bitcoin mining into a scarce powered-capacity landlord for AI; if Lake Mariner and Justified convert into recurring lease revenue on schedule and management extends the model to Muskie and Chesapeake with disciplined project finance, revenue can scale into the low billions and equity can still compound 3x+ despite multiple compression.
31 JOBY aerospace defense evtol transportation Joby Aviation, Inc. 2.7x 0.60 Joby can compound into a regulated air-mobility and defense platform if its FAA lead, Toyota-backed production ramp, and Blade/airport/airline distribution convert into dense early corridors and managed fleet contracts; the nonlinear upside comes from shifting from one-off aircraft proof points to recurring network, support, and defense revenue before dilution overwhelms value creation.
32 RLAY ai biotech healthcare Relay Therapeutics, Inc. 2.7x 0.40 Relay is a lead-asset proof-conversion story: if zovegalisib turns differentiated PI3Kα biology into approved products in breast cancer and vascular anomalies, the company can graduate from platform promise to focused franchise, with Dynamo adding capital efficiency and follow-on option value rather than carrying the valuation alone.
33 BKSY aerospace ai defense software space BlackSky Technology Inc. 2.7x 0.60 BlackSky can become a more valuable defense data utility if it converts Gen-3 performance into contracted orbital scarcity, standardized sovereign offerings, and trusted machine-speed workflows faster than launch friction and dilution erode per-share gains.
34 KTOS aerospace communications defense hardware space Kratos Defense & Security Solutions, Inc. 2.6x 0.60 Kratos sits in several defense bottlenecks—attritable aircraft, low-cost propulsion, hypersonic support and satellite ground systems—and if 2026-2027 proof points convert into repeat production, revenue can compound well above prime peers while the stock keeps a defense-tech premium.
35 CBRS ai cloud enterprise hardware semiconductors Cerebras Systems Inc. 2.6x 0.78 Cerebras can turn a genuine speed advantage in latency-sensitive AI into a much larger recurring capacity business, but the stock only compounds if CS-4, data-center megawatts, and broader customer distribution convert signed demand into durable cloud revenue before fast inference is priced like commodity compute.
36 OUST automation hardware robotics software transportation Ouster, Inc. 2.6x 0.50 Ouster can still create a 2-5x equity outcome by 2031 if Rev8, cameras, and workflow software turn it from a lidar box vendor into a repeatable perception-system supplier for roads, warehouses, yards, agriculture, and robots; the non-linearity comes from bundle expansion and recurring trust and workflow layers, but a 10x outcome from here still looks unlikely without much stronger software capture.
37 SMR ai automation energy hardware nuclear NuScale Power Corporation 2.6x 0.60 NuScale is a convex commercialization bet: if its U.S. regulatory lead, supplier readiness, and AI-era firm-power demand convert into one anchor U.S. project plus one credible international path, the business can re-rate from intermittent study revenue to a bankable nuclear platform with meaningful OEM, licensing, reservation, and lifecycle revenue by 2031.
38 ASTS communications defense hardware networking space AST SpaceMobile, Inc. 2.6x 0.64 AST can still compound strongly if it converts a real hardware-and-spectrum lead into a wholesale global coverage layer sold through carriers, governments, and high-value recovery workflows; the nonlinear upside comes from each new satellite, gateway, and approval unlocking revenue across the same network, but value capture must prove out fast enough to justify the infrastructure base.
39 SMCI ai cloud enterprise hardware networking Super Micro Computer, Inc. 2.6x 0.62 Supermicro can roughly triple equity value by 2031 if it converts today’s AI rack demand into repeatable deployment outcomes, keeps integrated cooling and support mix high, and proves that fast growth can be funded and collected without renewed compliance or working-capital stress.
40 TEM ai biotech healthcare medical devices software Tempus AI, Inc. 2.5x 0.65 Tempus can grow from a premium precision-oncology lab into a trusted execution rail for cancer care: diagnostics create proprietary longitudinal data, that data improves applications, and workflow embedment plus reimbursement wins can shift value capture toward higher-margin actions, not just tests.
41 BBAI ai defense enterprise software BigBear.ai Holdings, Inc. 2.5x 0.45 BigBear.ai can still create a strong 5-year outcome if it converts real defense and security demand into a trusted control layer for secure AI deployment, regulated screening, and auditable mission workflows; the upside is mix shift and distribution in sensitive environments, not owning the best model.
42 APUS biotech crypto healthcare software Apimeds Pharmaceuticals US, Inc. 2.5x 0.10 APUS is a survival-first option on turning expanded Apitox rights plus a trust-oriented digital-asset treasury surface into financeable cash flows; if debt and listing are stabilized, enterprise value can more than double by 2031, but common equity only wins if dilution and creditor leakage are contained.
43 ESTC ai cloud cybersecurity enterprise software Elastic N.V. 2.5x 0.56 Elastic is a credible AI-era picks-and-shovels software name: if rising machine-data volume keeps pulling search, monitoring, and security onto one governed backend, it can roughly double revenue and more than double equity value over five years, but the win depends on proving that extra workload becomes sticky platform economics rather than low-margin cloud pass-through.
44 S ai cloud cybersecurity enterprise software SentinelOne, Inc. 2.5x 0.60 SentinelOne can compound by turning endpoint telemetry into a broader AI-era security control layer across cloud, data, and autonomous operations; if module attach and partner-led distribution keep improving, revenue can outgrow software norms and the valuation gap to stronger cyber platforms can narrow.
45 CLS ai cloud communications hardware networking Celestica Inc. 2.5x 0.64 Celestica can still compound into a 2-3x equity outcome by 2031 if it turns fresh capital into qualified AI infrastructure capacity, expands from switching into rack-scale compute and lifecycle services, and proves it is a strategic deployment partner rather than a replaceable manufacturer.
46 IONQ cloud defense hardware quantum semiconductors IonQ, Inc. 2.5x 0.60 IonQ can grow into a larger strategic quantum infrastructure vendor if SkyWater turns roadmap speed and sovereign trust into repeat system, capacity, timing, and verification revenue; the stock does not need mass-market quantum by 2031, but it does need 2027 hardware proof so revenue growth outruns multiple compression.
47 COIN crypto enterprise finance software Coinbase Global, Inc. 2.4x 0.67 Coinbase can roughly 2.4x by 2031 if it completes the shift from cyclical crypto broker to regulated 24/7 financial rails, using trust, custody, stablecoin economics, derivatives, stocks, and tokenization to make revenue more durable before execution fees commoditize.
48 CRSP biotech healthcare CRISPR Therapeutics AG 2.4x 0.60 CRISPR Therapeutics already cleared the first trust gate with an approved CRISPR therapy; if CASGEVY scales into steadier economics and one or two owned assets become commercially credible by 2031, the stock can rerate from cash-backed platform optionality into a multi-franchise gene-medicine company.
49 LMND ai automation finance software Lemonade, Inc. 2.4x 0.46 Lemonade can more than double equity value over five years if AI-led claims efficiency, higher premium retention, and car-led expansion convert fast top-line growth into durable insurer economics before shopping pressure, regulation, and reinsurance capacity blunt the advantage.
50 QBTS cloud enterprise hardware quantum software D-Wave Quantum Inc. 2.4x 0.45 D-Wave can still create meaningful shareholder value by 2031 if it turns a few proven optimization deployments into a repeatable commercial stack across QCaaS, sovereign installs, and agent-embedded decision APIs, but because the stock already prices in scarcity, the return must come from real revenue scale rather than roadmap narrative.
51 SOUN ai automation automotive enterprise software SoundHound AI, Inc. 2.4x 0.40 SoundHound’s realistic upside is to become a workflow tollbooth for voice-led enterprise automation rather than a pure model vendor; if OASYS, Amelia, and a closed LivePerson deal turn fast deployments into sticky, verified, and increasingly outcome-linked interactions, revenue can scale into the low billions by 2031 even as generic AI pricing falls.
52 CORZ ai cloud crypto energy Core Scientific, Inc. 2.4x 0.72 Core Scientific’s 5-year upside comes from turning already-controlled power into contracted AI colocation revenue faster than peers can secure grid access, while using customer-backed and project-style financing to keep the balance sheet from becoming the bottleneck.
53 VICR ai defense energy hardware semiconductors Vicor Corporation 2.4x 0.62 Vicor controls a real AI-era bottleneck in dense power delivery near hotter chips; if it converts backlog, expands ChiP capacity on time, and makes licensing more repeatable, revenue can roughly triple by 2031 even as the valuation multiple cools from today's premium.
54 AMBA ai automotive hardware robotics semiconductors Ambarella, Inc. 2.3x 0.62 Ambarella can outgrow the broader semiconductor group if edge-AI design wins in cameras, vehicles, and robots convert into diversified production ramps; the non-linear upside is moving from a pure chip vendor toward a harder-to-displace deployment and verification control point as edge AI spreads.
55 NVDA ai hardware networking semiconductors software NVIDIA Corporation 2.3x 0.95 NVIDIA remains the default AI-factory stack across accelerators, systems, networking and workflow software; if AI infrastructure spend broadens from hyperscalers into sovereign and enterprise builds, the company can nearly double in value by 2031 even with some share loss and a lower terminal multiple than today.
56 CRWV ai cloud enterprise networking software CoreWeave, Inc. 2.3x 0.74 CoreWeave can still roughly triple equity value by 2031 if it keeps converting financed power and NVIDIA supply into live AI capacity, then protects usage pricing with inference, workflow, and trust attach before raw GPU supply normalizes.
57 RIOT ai crypto energy hardware Riot Platforms, Inc. 2.3x 0.65 Riot can create a solid 2-5x outcome by converting scarce approved power and in-house electrical execution into long-duration AI data-center cash flows, while using bitcoin mining as a flexible backstop; the real upside is a revenue-quality shift and capital-structure improvement, not just more mining.
58 RKLB aerospace communications defense hardware space Rocket Lab Corporation 2.3x 0.74 Rocket Lab is one of the few public companies that can turn AI-era demand for autonomy, secure communications, and rapid deployment into hard-to-copy physical revenue; if Neutron proves out and Iridium closes cleanly, it can graduate from premium launch supplier to broader mission infrastructure platform by 2031.
59 HUT ai cloud crypto energy hardware Hut 8 Corp. 2.3x 0.69 Hut 8 can compound from a miner-with-optionality into a power-backed AI infrastructure owner if it converts pre-sold Beacon Point and River Bend capacity into live cash-flowing campuses, proves project finance is repeatable, and recycles capital into new sites without reopening a parent-level dilution loop.
60 CRNC ai automotive cloud software Cerence Inc. 2.3x 0.55 Cerence’s realistic upside is not becoming the best model company; it is turning an embedded automotive voice footprint into a higher-value recurring control point where xUI, connected services, and trusted action workflows lift revenue per vehicle faster than legacy license pricing compresses.
61 APP advertising ai media software AppLovin Corporation 2.2x 0.62 AppLovin already runs an elite cash-generating performance ad engine; the 2031 upside is turning that engine into a broader outcomes network for commerce, lead generation, and connected TV, where embedded distribution, telemetry, and trusted measurement expand spend faster than valuation multiple compression offsets value creation.
62 RGTI cloud enterprise hardware quantum semiconductors Rigetti Computing, Inc. 2.2x 0.56 Rigetti is a scarce full-stack quantum hardware option: if Cepheus-class systems cross the proof gap and the company converts on-prem, HPC, and government demand into accepted deployments, revenue can scale from niche R&D to a small but real infrastructure business by 2031, but the stock already prices in partial success.
63 SPCX ai cloud communications defense space Space Exploration Technologies Corp. 2.2x 0.84 Mega-cap size limits venture-style upside, but SpaceX still owns rare AI-era choke points in launch, spectrum, secure government connectivity and compute deployment. If it converts next-generation network upgrades and AI capacity into durable recurring revenue faster than capex expands, equity value can still compound at a mid-teens rate through 2031.
64 RMBS ai cybersecurity hardware networking semiconductors Rambus Inc. 2.2x 0.60 Rambus is an asset-light tollbooth on rising AI memory complexity: if it keeps converting harder server-memory, interconnect and hardware-security requirements into qualified chip shipments plus recurring IP capture, revenue can scale from 850 to 2000 by 2031 without owning fabs, though upside is capped by standards-based pricing and customer insourcing risk.
65 PATH ai automation cloud enterprise software UiPath, Inc. 2.2x 0.56 UiPath can roughly double by 2031 if it proves that enterprise AI needs a governed execution layer, letting Maestro, testing, document workflows, and trust controls expand wallet share even as basic automation authoring gets cheaper.
66 AVAV aerospace automation defense robotics software AeroVironment, Inc. 2.2x 0.60 AeroVironment can still compound well through 2031 because it sits where AI-era defense demand meets real procurement trust: battle-proven systems, qualified production, and a growing mission software layer. If repeat strike, tactical UAS, counter-UAS and BlueHalo-derived programs convert into steadier procurement, revenue can outgrow the sector even without software-like margins.
67 FIVN ai cloud communications enterprise software Five9, Inc. 2.2x 0.40 Five9 can compound meaningfully if it turns AI from a seat-risk into a higher-value workflow and trust revenue stream, using its routing, telephony, integration depth, and enterprise compliance posture to stay embedded as contact centers automate.
68 FN automation communications hardware networking Fabrinet 2.2x 0.60 Fabrinet can remain a strong AI-infrastructure compounder through 2031 if it converts new Thailand capacity and trusted optical-packaging know-how into broader multi-customer volume, roughly doubling revenue while preserving a premium to ordinary contract manufacturers.
69 RDVT ai cybersecurity enterprise finance software Red Violet, Inc. 2.2x 0.50 RDVT can more than double by 2031 if it keeps moving from paid lookups to being the verification gate inside fraud, compliance, public-sector, and field-safety workflows; the August 2026 raise adds data-rights and tuck-in optionality without making capex the bottleneck.
70 SYM ai automation enterprise robotics software Symbotic Inc. 2.2x 0.64 Symbotic can roughly double equity value by 2031 if it converts its unusually large backlog into live sites on time, lifts recurring software and service profit per warehouse, and uses Exol, ARMS, SymMicro, and higher-level control software to diversify beyond Walmart without losing pricing discipline.
71 AMKR ai automotive hardware semiconductors Amkor Technology, Inc. 2.2x 0.67 Amkor is a leveraged bet on advanced packaging staying scarce and qualification-heavy as AI, chiplets and automotive complexity push value downstream; if Arizona becomes customer-backed reserved infrastructure rather than just more capex, Amkor can nearly double revenue with only a modest rerating.
72 ZS ai cloud cybersecurity enterprise software Zscaler, Inc. 2.2x 0.60 Zscaler still looks like a premium cyber compounder because its inline control point, installed-base upsell motion, and partner distribution let it capture more spend as security shifts from human users to apps, data, workloads, and AI agents; the upside is meaningful if non-seat monetization grows faster than bundle-driven pricing pressure.
73 AAOI ai communications hardware networking semiconductors Applied Optoelectronics, Inc. 2.1x 0.58 AOI is a leveraged way to own the bandwidth bottleneck of AI clusters: if it turns 800G and 1.6 terabit qualification, Texas and Taiwan capacity, and tighter customer relationships into repeatable output before industry supply catches up, revenue can scale far faster than a normal hardware vendor, even though dilution risk and eventual multiple compression will limit how much of that growth reaches equity holders.
74 ALAB ai cloud hardware networking semiconductors Astera Labs, Inc. 2.1x 0.78 Astera can outgrow normal semiconductors if Scorpio turns the company from a premium point-component vendor into a broader rack-connectivity control layer, letting each new AI rack carry more Astera silicon, software, validation, and support content before valuation fully matures.
75 NOW ai automation cloud enterprise software ServiceNow, Inc. 2.1x 0.67 ServiceNow can outgrow large-cap software peers by becoming the trusted execution and governance layer for enterprise AI work across many systems, with non-seat monetization and cross-sell offsetting some seat compression and supporting a little over 2x equity value over five years.
76 ON ai automation automotive hardware semiconductors ON Semiconductor Corporation 2.1x 0.65 onsemi can compound value if AI server power, EV content, and industrial automation raise both demand and factory loading at once, while Synaptics and system-level offerings move it from a cyclical parts vendor toward a more trusted power-and-control franchise.
77 BFLY ai enterprise healthcare medical devices software Butterfly Network, Inc. 2.1x 0.57 Butterfly can plausibly create a 2x+ equity outcome by 2031 if it converts a differentiated handheld ultrasound franchise into a higher-quality mix of enterprise workflow, regulated trust software, and repeatable embedded licensing; AI expands scan volume, but the real upside comes from owning the verified clinical workflow around the scan.
78 NTRA ai biotech healthcare medical devices Natera, Inc. 2.1x 0.65 Natera can compound from a fast-growing test seller into a recurring oncology and transplant surveillance system: more clinical proof wins more coverage, better coverage lifts testing cadence and realized price, and higher scale funds still more evidence. The stock can work from here if oncology keeps broadening, but returns likely come from revenue growth more than further multiple expansion.
79 PL ai defense enterprise software space Planet Labs PBC 2.1x 0.60 Planet can grow from an imagery vendor into a trusted Earth-monitoring utility: its daily proprietary archive, sovereign-friendly delivery model, and workflow APIs should let it compound revenue well above aerospace norms if it converts backlog, scales Pelican capacity, and lifts mix toward higher-value analytics and verification rather than bespoke services.
80 SKHY ai hardware semiconductors SK hynix Inc. 2.1x 0.76 SK hynix sells a scarce physical AI input that customers need now, not later. If it keeps HBM leadership, converts scarcity into stickier supply contracts, and brings packaging and fab capacity online on time, it can more than double per-share value by 2031 without needing permanent peak-cycle pricing.
81 AVGO ai enterprise networking semiconductors software Broadcom Inc. 2.1x 0.78 Broadcom should compound as one of the few scaled vendors that can monetize both AI cluster build-outs and the private-cloud control stack around them; if multi-year custom silicon programs convert and VMware becomes a trusted AI operations layer, revenue can plausibly roughly double by 2031 even with some multiple compression.
82 DDOG ai cloud cybersecurity enterprise software Datadog, Inc. 2.1x 0.60 Datadog can still roughly double equity value by 2031 if AI-driven software complexity keeps pushing more telemetry, security, and remediation workflows onto its unified platform, letting it capture more value from trusted operating workflows rather than raw ingest alone.
83 META advertising ai communications hardware media Meta Platforms, Inc. 2.1x 0.78 Meta can turn AI from a relevance upgrade into a broader monetization stack across ads, messaging, subscriptions, APIs, and devices; if the core cash engine keeps funding compute without major regulatory damage, revenue can reach 420,000 by 2031 and equity value can roughly double.
84 MU ai cloud enterprise hardware semiconductors Micron Technology, Inc. 2.1x 0.80 Micron can turn AI-era memory scarcity into a much larger and somewhat less cyclical earnings base if HBM roadmap execution, strategic customer agreements and on-time U.S. capacity expansion preserve premium mix through 2031; the upside is strong without needing software-like economics, but it still must avoid a classic supply-driven reset.
85 ANET ai cloud hardware networking software Arista Networks, Inc. 2.1x 0.76 Arista is an AI-networking toll road with unusually strong software workflow lock-in for a hardware company; if it converts AI fabric demand into broader enterprise share and higher-value control, assurance, and support attach, revenue can nearly triple by 2031 and equity can still roughly double despite multiple compression.
86 TSLA ai automotive energy robotics transportation Tesla, Inc. 2.1x 0.70 Tesla’s 2031 upside is not just more vehicles; it is higher revenue density per customer across cars, charging, energy storage and autonomy, with the energy platform funding a slower but real shift toward recurring mile- and dispatch-linked revenue.
87 AMZN advertising ai cloud enterprise transportation Amazon.com, Inc. 2.0x 0.82 Amazon remains a rare mega-cap with two AI-era toll booths: scarce compute on AWS and dense commerce/logistics distribution. If it converts power-backed capacity into durable cloud and agent workloads while keeping ads and seller services compounding, a little-over-2x equity outcome by 2031 is plausible without needing a breakthrough consumer AI product.
88 MPWR ai automotive enterprise hardware semiconductors Monolithic Power Systems, Inc. 2.0x 0.70 Monolithic Power Systems can still roughly double equity value by 2031 if it converts AI rack power complexity into higher content per platform, expands from chip sockets into modules and validated system solutions, and secures enough outsourced capacity to keep enterprise-data growth from becoming supply-limited.
89 MRVL ai cloud hardware networking semiconductors Marvell Technology, Inc. 2.0x 0.68 Marvell can still compound meaningfully if it turns a handful of hyperscaler AI wins into broader content per rack across custom silicon, optics, switching and memory attach, but the upside is capped by customer concentration, outsourced manufacturing choke points and an already premium starting valuation.
90 MSFT ai cloud cybersecurity enterprise software Microsoft Corporation 2.0x 0.82 Microsoft can still roughly double by 2031 because it monetizes enterprise AI at several layers at once—Azure capacity, workplace software, identity, security, data, and developer tooling—while its installed base and admin control surfaces keep AI workflows inside its stack even as underlying models get cheaper.
91 NET ai cloud cybersecurity networking software Cloudflare, Inc. 2.0x 0.65 Cloudflare can roughly double equity value by 2031 if it turns its in-path network and trust layer into higher-value revenue across security, developer compute, and verified agent traffic, letting AI expand monetizable surfaces faster than pricing normalizes and valuation compresses.
92 VRT ai automation energy enterprise hardware Vertiv Holdings Co 2.0x 0.72 Vertiv is an AI-infrastructure toll collector: as racks get denser and sites get harder to energize and cool, its integrated power, thermal, commissioning, and service stack can roughly double revenue by 2031, with equity upside driven by share gains and service attach more than by multiple expansion.
93 JBL ai automation cloud hardware medical devices Jabil Inc. 2.0x 0.55 Jabil can move from a generic contract manufacturer toward a scarcer AI hardware execution layer: if it deepens share in rack, power, cooling, photonics, logistics, and regulated programs while keeping capex asset-light and inventory disciplined, revenue can reach the low-50 billions and the equity can hold a premium to classic EMS peers.
94 ORCL ai cloud enterprise healthcare software Oracle Corporation 2.0x 0.70 Oracle can outgrow mature software peers through 2031 if it turns AI backlog into live OCI capacity, keeps database and workflow automation inside its governed stack, and shifts AI pricing toward usage and outcomes; that can more than double revenue without needing a pure-play AI valuation.
95 TSM ai hardware semiconductors Taiwan Semiconductor Manufacturing Company Limited 2.0x 0.88 TSMC can still compound from a huge base because AI demand is spreading beyond GPUs into CPUs, custom chips, networking and edge devices, keeping scarce leading-edge wafers and advanced packaging full; if it also commercializes capacity assurance and resilience, revenue can outgrow the broader chip market even without major multiple expansion.
96 CDNS ai enterprise hardware semiconductors software Cadence Design Systems, Inc. 2.0x 0.74 Cadence should compound above normal software through 2031 because AI raises chip, packaging, and system-design complexity, which expands spend on the validated workflows Cadence already controls; upside comes from deeper wallet share plus new trust and compute monetization inside existing accounts, while the main cap is premium valuation and export-policy friction.
97 COHR ai communications hardware networking semiconductors Coherent Corp. 2.0x 0.70 Coherent can roughly double equity value by 2031 if it converts scarce, qualified photonics capacity into durable share gains across AI interconnect, optical switching, and higher-content subsystems; the upside comes from owning a real bandwidth bottleneck, while the main debate is whether scarcity lasts long enough to outrun capex, customer leverage, and later pricing normalization.
98 GOOG advertising ai cloud enterprise media Alphabet Inc. 2.0x 0.78 Alphabet can still nearly double by 2031 if it keeps high-intent activity inside Search, YouTube, Android, Chrome, and Workspace while converting AI demand into Cloud, enterprise trust tooling, and action-based monetization; the edge is owning both distribution and the compute stack, but returns depend on proving capex and remedies do not dilute elite ad economics.
99 SITM ai communications hardware networking semiconductors SiTime Corporation 2.0x 0.60 SiTime can turn a premium MEMS timing niche into a broader precision-timing franchise by retaining the acquired Renesas revenue base, raising content per AI and communications system, and layering in modest software, security and lifecycle services; that can drive roughly 2x enterprise value even with multiple compression.
100 CRM ai automation cloud enterprise software Salesforce, Inc. 1.9x 0.60 Salesforce can still compound meaningfully if it converts a dominant CRM workflow footprint into paid AI actions, data services, and trust-governed automation before seat pressure and external agent surfaces compress legacy pricing.
101 SNOW ai cloud enterprise software Snowflake Inc. 1.9x 0.60 Snowflake can grow from premium data warehouse to governed AI execution layer: if it keeps data, policy, model routing, and audit trails inside one multi-cloud control plane, agent-driven workload growth can more than triple revenue by 2031 even as the valuation multiple normalizes.
102 SNPS ai cloud enterprise semiconductors software Synopsys, Inc. 1.9x 0.80 Synopsys should outgrow most large software peers because AI raises the complexity of chips, packages, and full systems, pushing more spend toward trusted, foundry-linked design workflows; the upside comes from Ansys cross-sell, cloud governance, and agentic execution layers rather than generic AI hype.
103 AMD ai hardware networking semiconductors software Advanced Micro Devices, Inc. 1.9x 0.72 AMD is one of the few scaled public companies that can monetize the AI buildout across CPU, GPU, networking and rack systems; if Helios shipments and ROCm maturity turn recent design wins into repeat deployments, revenue can compound hard through 2031, though shareholder returns should be moderated by multiple normalization from an already premium starting point.
104 PLTR ai automation defense enterprise software Palantir Technologies Inc. 1.9x 0.74 Palantir can keep compounding as a governed operating layer for high-stakes AI workflows, especially in defense and regulated enterprise, but the equity case is constrained by an already extreme starting valuation even if the business meaningfully outgrows software peers.
105 CRDO ai hardware networking semiconductors Credo Technology Group Holding Ltd 1.9x 0.62 Credo is a real AI-fabric beneficiary: it can extend from active electrical cables into optics, digital signal processors, retimers and memory interconnect, with hardware-linked diagnostics deepening socket value; the business can compound hard, but shareholder upside is moderated because much of that success is already priced in.
106 MTSI communications defense hardware networking semiconductors MACOM Technology Solutions Holdings, Inc. 1.9x 0.62 MACOM is not a thin AI software wrapper; it sells qualified optical and RF content plus scarce compound-semiconductor capacity. If it converts backlog and design wins into repeat 800G/1.6T, defense and satellite shipments while moving modestly up-stack into higher-content solutions, revenue can reach 3600 by 2031 and equity value can roughly double.
107 CEG energy enterprise nuclear Constellation Energy Corporation 1.8x 0.78 Constellation should outgrow utility norms by converting scarce licensed nuclear output and flexible gas capacity into long-duration, reliability-priced contracts for AI, industrial and public loads; the non-linear upside comes from contract form, life extensions, restarts and powered-campus monetization more than heroic greenfield buildouts.
108 LSCC ai cloud hardware semiconductors software Lattice Semiconductor Corporation 1.8x 0.58 Lattice can use AMI to move from a niche low-power FPGA vendor toward a trusted control-stack supplier for AI servers and physical systems; if it converts silicon design wins into recurring firmware and lifecycle revenue while clearing post-deal leverage, revenue can scale toward 2650 by 2031 and equity can roughly double.
109 DELL ai cloud enterprise hardware networking Dell Technologies Inc. 1.8x 0.60 Dell can turn an AI server surge into a broader enterprise infrastructure compounding story if it keeps converting scarce AI hardware demand into storage, support, financing and consumption revenue before rack-scale systems standardize and margins compress.
110 HPE cloud enterprise hardware networking software Hewlett Packard Enterprise Company 1.8x 0.60 HPE can compound as an AI-era enterprise infrastructure operator if it converts AI backlog into shipped revenue, uses Juniper to make networking a durable second engine, and turns GreenLake from an attach into the operating layer that keeps private AI estates sticky.
111 BWXT aerospace defense energy nuclear BWX Technologies, Inc. 1.8x 0.76 BWXT is a scarce owner of licensed nuclear throughput and trust-heavy defense relationships; if it converts capacity expansion, funded backlog and fuel assurance into higher-quality bookings, the stock can roughly double by 2031 without needing a reactor-technology moonshot.
112 STEM ai automation energy enterprise software Stem, Inc. 1.8x 0.45 Stem is a small but real renewable-asset control-layer company; if it survives the financing squeeze and turns installed monitoring and PPC footprints into recurring EMS, verification, and partner-distributed software, modest enterprise-value growth can still drive nonlinear equity upside from today’s depressed base.
113 LITE ai communications hardware networking semiconductors Lumentum Holdings Inc. 1.7x 0.67 Lumentum is a real AI infrastructure beneficiary because faster AI clusters need more lasers, transceivers, and optical switching, and it owns qualified photonics capacity that is hard to copy quickly; the catch is that today’s equity already prices in much of that success, so the five-year win condition is strong revenue compounding plus only partial multiple compression.
114 TWST ai automation biotech healthcare Twist Bioscience Corporation 1.7x 0.55 Twist is a rare AI-biology picks-and-shovels company where cheaper design should increase demand for its physical output; if it converts that demand into higher utilization, strategic supply agreements, and trusted workflow revenue, revenue can scale sharply by 2031 even as the valuation multiple normalizes.
115 VST ai energy nuclear Vistra Corp. 1.7x 0.72 Vistra is a scarce-power allocator, not a pure utility: if it closes Cogentrix, ramps Meta-linked nuclear contracts, and standardizes large-load power products, it can convert AI-era power scarcity into better cash-flow quality and a meaningfully larger equity base by 2031.
116 ASML automation hardware semiconductors software ASML Holding N.V. 1.7x 0.86 ASML should keep compounding as AI raises lithography intensity and service attach, but its already-premium valuation means shareholder upside depends on converting scarce capacity into sustained revenue, margin and recurring installed-base capture rather than on another major multiple re-rate.
117 NTAP ai cloud enterprise hardware software NetApp, Inc. 1.6x 0.60 NetApp should compound as an AI-era data operating layer: ONTAP workflow embed, all-flash refresh, cloud attach, and newer recovery and data-activation products can lift revenue and quality of revenue, but hyperscaler-owned distribution likely caps a full software-style rerating.
118 PWR automation communications energy Quanta Services, Inc. 1.6x 0.60 Quanta is a scarce execution layer for the AI-power buildout: if it keeps converting grid, generation and large-load demand into broader electrical scope, negotiated programs and selective higher-value service overlays, revenue can compound meaningfully through 2031. The limiter is that shareholders still own premium contractor economics, so the likely outcome is strong compounding rather than explosive multiple expansion.
119 EQIX ai cloud enterprise hardware networking Equinix, Inc. 1.6x 0.80 Equinix should keep compounding as AI pushes more enterprise, hybrid and regulated workloads into scarce metro hubs where neutral connectivity and ecosystem density matter; the 2031 upside comes from turning power-secured capacity into higher-value recurring revenue, not from a software-style rerating.
120 PANW ai cloud cybersecurity enterprise software Palo Alto Networks, Inc. 1.6x 0.68 Palo Alto Networks should keep compounding faster than large-cap software as AI expands attack surfaces, machine identities and vendor consolidation, but from a premium starting valuation the stock likely wins through deeper wallet share, trusted control points and cash-flow durability rather than another dramatic rerating.
121 NEE energy nuclear NextEra Energy, Inc. 1.6x 0.80 NextEra is a scarce-power compounder: it owns regulated interconnection, a large build engine and credible ways to package speed-to-power for AI-driven load growth, so revenue can outgrow utility norms; the key question is how much of that demand survives approvals, funding needs and dilution to reach per-share value.
122 CRWD ai cloud cybersecurity enterprise software CrowdStrike Holdings, Inc. 1.5x 0.70 CrowdStrike should keep compounding as AI expands attack volume, machine identities, and telemetry, pushing customers toward a unified security control layer; the business can grow very fast, but the stock already prices in elite execution, so the likely win is durable compounding rather than a dramatic re-rating.
123 TLN ai cloud energy nuclear Talen Energy Corporation 1.5x 0.70 TLN already owns scarce PJM-adjacent nuclear and dispatchable megawatts; if it converts part of that scarcity into longer-duration large-load and reliability-priced contracts while digesting Cornerstone and reducing leverage, equity can compound materially faster than revenue over the next five years.
124 ARM ai cloud hardware semiconductors software Arm Holdings plc 1.5x 0.80 Arm owns a rare architecture choke point in efficient compute; if Neoverse, Armv9/CSS and selective silicon raise dollars captured per AI system faster than RISC-V and partner pushback erode pricing, revenue can roughly quadruple by 2031 even if the stock only compounds at around market rates because today’s valuation is already rich.
125 ETN aerospace automation energy hardware software Eaton Corporation plc 1.5x 0.74 Eaton is an AI-electrification tollbooth: if it keeps turning backlog into shipments, exits Mobility cleanly, and adds more service, thermal, and trust-layer revenue to critical power projects, it can outgrow most industrial peers even without a dramatic rerating.